These methodologies offer a potent platform for enhancing treatment strategies and advancing diagnostic pathologies providing a foundation for stratifying patients for immune checkpoint inhibitor (ICI) therapies based on the spatial dynamics of PD-1/PD-L1 interactions within the tumor microenvironment. The gene discussed is CD274; the disease is neoplasm.